Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2006

01-09-2006 | Preclinical study

Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier

Authors: Cheryl M. Lewis, Brittney-Shea Herbert, Dawei Bu, Shane Halloway, Adam Beck, Ashleen Shadeo, Cindy Zhang, Raheela Ashfaq, Jerry W. Shay, David M. Euhus

Published in: Breast Cancer Research and Treatment | Issue 1/2006

Login to get access
Metadata
Title
Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier
Authors
Cheryl M. Lewis
Brittney-Shea Herbert
Dawei Bu
Shane Halloway
Adam Beck
Ashleen Shadeo
Cindy Zhang
Raheela Ashfaq
Jerry W. Shay
David M. Euhus
Publication date
01-09-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9189-9

Other articles of this Issue 1/2006

Breast Cancer Research and Treatment 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine